Search Results

Baxter Appoints Patricia Morrison and Amy Wendell to its Board

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed Patricia B. (Patty) Morrison, former Cardinal Health executive vice president and chief information officer, and Amy A. Wendell, former Covidien senior vice president of strategy and business development, to its board of directors. These appointments will be effective Feb.

Baxter to Present at the 37th Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 7, 2019 at 10 a.m. Pacific Time.

Baxter Unveils New Products at the ASMBS – Obesity Week Meeting to Help Surgeons Overcome Challenges During Bariatric Surgery

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, revealed its Peri-Strips Dry with Veritas (PSDV) Circular Staple Line Reinforcement with Secure Grip technology, the latest evolution in a product portfolio that has more than 20 years of proven clinical use in surgical buttressing and soft tissue repair.

Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today a quarterly cash dividend and an expanded authorization for its share repurchase program. The Board of Directors of Baxter has declared a quarterly cash dividend of $0.19 per share of common stock, payable on Jan. 2, 2019, to stockholders of record as of Dec. 3, 2018. The indicated annual dividend rate is $0.76 per share of common stock.

Baxter Highlights Data at ISPOR Europe 2018 on Clinical and Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter International Inc. (NYSE:BAX), a leading global medical products company, is presenting four health economics and outcomes research (HEOR) analyses this week at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2018 meeting. The studies evaluated potential clinical and economic impacts of various products and practices associated with malnutrition and surgical procedures.

Baxter Introduces New Tisseel Prima Syringe at 2018 American Association of Gynecologic Laparoscopists Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today unveiled the latest design enhancements for its fibrin sealant product, the Tisseel Prima syringe, at the 2018 American Association of Gynecologic Laparoscopists (AAGL) meeting.

Baxter to Present at Citi's 2018 Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at Citi’s 2018 Global Healthcare Conference on Thursday, December 6, 2018, in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 11:45 a.m. EST. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through March 7, 2019.

Flexibility That Works for Baxter Parents

At a time of changing family dynamics, we understand the increasing demands placed on our employees to balance their personal and work lives

Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.

Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies

Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the company’s next-generation technology for continuous renal replacement and organ support therapies.